Atazanavir
Links shared publicly online about this topic
REYATAZ (Atazanavir) drug information from MPR
empr.com — “REYATAZ (Atazanavir) drug information for HIV~antivirals from MPR including side effects, drug interactions, dosing, contraindications and warnings/precautions.” View full resource at empr.com
Most Recently Shared on June 7, 2011 at 6:03 am By:
MPR News: REYATAZ: Adults: updated dosing for pregnant patients. http://bit.ly/lmwT8f
Atazanavir in Pregnancy: 155 Cases in London Clinics - The Body
thebody.com — “Atazanavir is increasingly used in pregnancy. There are limited data to guide this use.” View full resource at thebody.com
Most Recently Shared on May 26, 2011 at 2:01 pm By:
Atazanavir in Pregnancy: 155 Cases in London Clinics http://bit.ly/mktWb6 #hiv #aids #treatment #reyataz
Reyataz (atazanavir) label revised, adding dosing recommendations for pregnancy and postpartum period
drugs.com — “Reyataz (atazanavir sulfate) is used to treat HIV Infection. Includes Reyataz side effects, interactions and indications.” View full resource at drugs.com
Most Recently Shared on February 8, 2011 at 10:03 pm By:
Drugs and Devices OW OW Health
Reyataz (atazanavir) label revised, adding dosing recommendations for pregnancy and postpartum period: ROC... http://bit.ly/gmXITr #drug
Reyataz (Atazanavir Sulfate), For HIV Positive Pregnant Women, Gets European Labeling Update Approval
medicalnewstoday.com — “Following new data from study AI424-182 on pregnant women living with HIV, the European Commission approved a labeling update for Reyataz (atazanavir sulfate). The announcement was made by Bristol” View full resource at medicalnewstoday.com
Most Recently Shared on November 28, 2011 at 1:05 pm By:
Reyataz (Atazanavir Sulfate), For HIV Positive Pregnant Women, Gets European Labeling Update Approval: Following... http://t.co/EFej2hOk
Reyataz (Atazanavir) Label Revised, Adding Dosing Recommendations for Pregnancy and Postpartum Period - The Body
thebody.com — “On February 4, 2011, FDA approved new labeling for Reyataz (atazanavir) to include dosing recommendations for treatment of HIV-1 infection during ...” View full resource at thebody.com
Most Recently Shared on February 14, 2011 at 3:01 pm By:
Reyataz (Atazanavir) Label Revised, Adding Dosing Recommendations for Pregnancy and Postpartum Period http://bit.ly/ibypAU #hiv #aids
Maraviroc Plus Atazanavir/r Without Nukes Versus Standard of Care: 48-Week Results - The Body
thebody.com — “Updated results from a Pfizer-sponsored study of dual therapy maraviroc plus atazanavir/r compared to standard of care atazanavir/r plus tenofovir/FTC ...” View full resource at thebody.com
Most Recently Shared on September 2, 2011 at 12:00 pm By:
IAS 2011: Maraviroc Plus Atazanavir/r Without Nukes Versus Standard of Care: 48-Week Results http://t.co/Oy3XioE #ias2011 #hiv #aids
HIV/AIDS Resource Center for Women - Atazanavir Levels Indicate Need for Higher Dose During Pregnancy
thebody.com — “Atazanavir Levels Indicate Need for Higher Dose During Pregnancy, at The Body, the complete HIV/AIDS resource.” View full resource at thebody.com
Most Recently Shared on June 6, 2011 at 12:00 pm By:
Atazanavir Levels Indicate Need for Higher Dose During Pregnancy http://bit.ly/jm0rbJ #hiv #aids #antiretrovirals #reyataz
Once-Daily 150-mg Maraviroc Explored in People Taking Atazanavir/Ritonavir - The Body
thebody.com — “HIV-positive people taking standard-dose atazanavir/ritonavir plus 150 mg of maraviroc once-daily had lower maraviroc maximum concentrations (Cmax) and ...” View full resource at thebody.com
Most Recently Shared on June 7, 2011 at 12:00 pm By:
Once-Daily 150-mg Maraviroc Explored in People Taking Atazanavir/Ritonavir http://bit.ly/mmZtMC #hiv #aids #antiretrovirals #reyataz
A Slice of Atazanavir, but Hold the Ritonavir: Switch to Unboosted Dose Still Effective After 120 Weeks, With Good Lipid Findings - The Body
thebody.com — “Myles is the editorial director of TheBody.com and TheBodyPRO.com.” View full resource at thebody.com
Most Recently Shared on September 13, 2010 at 2:01 pm By:
Switch to Unboosted Atazanavir Still Effective After 120 Weeks, With Good Lipid Findings http://bit.ly/9eWipf #hiv #aids #reyataz #ICAAC
ingentaconnect Ritonavir-boosted atazanavir: cost-effective first-line HIV thera...
ingentaconnect.com — “ingentaconnect Ritonavir-boosted atazanavir: cost-effective first-line HIV thera...” View full resource at ingentaconnect.com
Most Recently Shared on January 11, 2011 at 6:07 pm By:
Ritonavir-boosted atazanavir: cost-effective first-line HIV therapy: (Source: PharmacoEconomics and Outcomes News) http://bit.ly/eADAMr
FDA grants Matrix tentative approval under PEPFAR for Atazanavir Sulfate Capsules ANDA
news-medical.net — “Mylan Inc. today announced that its subsidiary Matrix Laboratories Limited has received tentative approval from the U.S. Food and Drug Administration (FDA) under the President's Emergency Plan for AIDS Relief (PEPFAR) for its Abbreviated New Drug Application (ANDA) for Atazanavir Sulfate Capsules, 150 mg and 300 mg. This product will be eligible for purchase outside the U.S. in certain developing countries.” View full resource at news-medical.net
Most Recently Shared on October 5, 2010 at 12:13 pm By:
FDA grants Matrix tentative approval under PEPFAR for Atazanavir Sulfate Capsules ANDA: Mylan Inc. today announced... http://bit.ly/df5qFj
In the Real Life Setting, Boosted REYATAZ® (atazanavir/ritonavir) Proves as Effective in Women Living with HIV as Men
prweb.com — “Boosted REYATAZ shows durable viral suppression in antiretroviral-experienced women living with HIV, in a gender-specific sub-analysis of a large retrospective cohort study.1” View full resource at prweb.com
Most Recently Shared on July 21, 2011 at 7:10 pm By:
In the Real Life Setting, Boosted REYATAZ® (atazanavir/ritonavir)...: Boosted REYATAZ shows durable viral suppr... http://bit.ly/rlkIXm
HIV & AIDS Information :: Atazanavir associated with significant risk of kidney stones and renal impairment
aidsmap.com — “The latest worldwide HIV/AIDS news and updates, including treatment, prevention, and hepatitis and TB co-infections.” View full resource at aidsmap.com
Most Recently Shared on April 14, 2011 at 10:47 pm By:
Bristol-Myers Squibb Signs New Agreement To Expand Access To Reyataz(R) (Atazanavir Sulfate) In Sub-Saharan Africa And India
medicalnewstoday.com — “Bristol-Myers Squibb Company (NYSE: BMY) today announced a new agreement to expand access to Reyataz® (atazanavir sulfate). The immunity-from-suit agreement signed with Matrix Laboratories Lim” View full resource at medicalnewstoday.com
Most Recently Shared on June 29, 2011 at 12:05 pm By:
Bristol-Myers Squibb Signs New Agreement To Expand Access To Reyataz(R) (Atazanavir Sulfate) In Sub-Saharan Africa And... http://mnt.to/3XNk
The Bilirubin-Increasing Drug Atazanavir Improves Endothelial Function in Patients With Type 2 Diabetes Mellitus -- Dekker et al. 31 (2): 458 -- Arteriosclerosis, Thrombosis, and Vascular Biology
atvb.ahajournals.org — “The Bilirubin-Increasing Drug Atazanavir Improves Endothelial Function in Patients With Type 2 Diabetes Mellitus -- Dekker et al. 31 (2): 458 -- Arteriosclerosis, Thrombosis, and Vascular Biology” View full resource at atvb.ahajournals.org
Most Recently Shared on January 24, 2011 at 12:18 pm By:
James Underberg Internist, Physician, and Doctor
The Bilirubin-Increasing Drug Atazanavir Improves Endothelial Function in Patients With Type 2 Diabetes Mellitus http://viigo.im/5R4r
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Related WisdomCards
Related Health Centers
Featuring the top 3 experts for this topic
-
MPR
eMPR.com provides up-to-date, concise drug information at the point-of-care.
-
The Body
The Complete HIV/AIDS Resource.
-
Drugs and Devices OW
Organizing drug and medical device resources shared by health experts, advocates, and organizations into WisdomCards.
Advertisement
